Comerica Bank Buys 16,275 Shares of Bath & Body Works, Inc. $BBWI

Key Points

• Comerica Bank increased its stake in Bath & Body Works by 20.2%, holding 96,863 shares valued at approximately $2.94 million as of the latest SEC filing.
• Bath & Body Works announced a quarterly dividend of $0.20 per share, resulting in an annualized yield of 2.7% for shareholders.
• Analysts have mixed views on the stock, with 12 analysts rating it a buy and 3 holding, while the consensus price target is set at $41.62.

Comerica Bank raised its stake in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 20.2% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 96,863 shares of the company's stock after purchasing an additional 16,275 shares during the period. Comerica Bank's holdings in Bath & Body Works were worth $2,937,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also made changes to their positions in the company. SVB Wealth LLC bought a new position in shares of Bath & Body Works during the 1st quarter valued at about $35,000. Golden State Wealth Management LLC boosted its holdings in shares of Bath & Body Works by 94.7% during the 1st quarter. Golden State Wealth Management LLC now owns 1,320 shares of the company's stock valued at $40,000 after purchasing an additional 642 shares during the last quarter. UMB Bank n.a. boosted its holdings in shares of Bath & Body Works by 65.9% during the 1st quarter. UMB Bank n.a. now owns 1,501 shares of the company's stock valued at $46,000 after purchasing an additional 596 shares during the last quarter. Ancora Advisors LLC bought a new position in shares of Bath & Body Works during the 4th quarter valued at about $67,000. Finally, GKV Capital Management Co. Inc. purchased a new position in shares of Bath & Body Works in the 1st quarter worth $69,000. Institutional investors own 95.14% of the company's stock.

Wall Street Analyst Weigh In

A number of brokerages have commented on BBWI. Citigroup dropped their price objective on shares of Bath & Body Works from $42.00 to $40.00 and set a "buy" rating for the company in a research note on Tuesday, August 19th. Wall Street Zen cut shares of Bath & Body Works from a "buy" rating to a "hold" rating in a research note on Saturday, August 9th. Piper Sandler set a $39.00 price objective on shares of Bath & Body Works and gave the stock an "overweight" rating in a research note on Thursday, May 15th. Telsey Advisory Group reissued an "outperform" rating and issued a $38.00 price objective on shares of Bath & Body Works in a research note on Thursday, August 28th. Finally, UBS Group dropped their price objective on shares of Bath & Body Works from $36.00 to $32.00 and set a "neutral" rating for the company in a research note on Friday, August 29th. Twelve analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $41.62.

Bath & Body Works Stock Down 3.7%

BBWI traded down $1.18 on Friday, reaching $30.69. 2,462,967 shares of the company traded hands, compared to its average volume of 5,218,515. Bath & Body Works, Inc. has a one year low of $24.94 and a one year high of $41.87. The firm has a fifty day simple moving average of $30.75 and a two-hundred day simple moving average of $30.65. The company has a market cap of $6.33 billion, a P/E ratio of 9.13, a price-to-earnings-growth ratio of 1.05 and a beta of 1.49.

Bath & Body Works (NYSE:BBWI - Get Free Report) last announced its quarterly earnings data on Thursday, August 28th. The company reported $0.37 earnings per share for the quarter, meeting analysts' consensus estimates of $0.37. Bath & Body Works had a net margin of 9.88% and a negative return on equity of 48.43%. The company had revenue of $1.55 billion during the quarter, compared to analyst estimates of $1.55 billion. During the same quarter last year, the business posted $0.37 EPS. The firm's revenue for the quarter was down .8% on a year-over-year basis. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. On average, equities analysts forecast that Bath & Body Works, Inc. will post 3.3 earnings per share for the current year.

Bath & Body Works Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 5th. Investors of record on Friday, August 22nd will be issued a dividend of $0.20 per share. The ex-dividend date is Friday, August 22nd. This represents a $0.80 dividend on an annualized basis and a yield of 2.6%. Bath & Body Works's dividend payout ratio (DPR) is presently 23.74%.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.